By Abigail Townsend
Date: Thursday 16 Oct 2025
(Sharecast News) - Legal action against US healthcare giant Johnson & Johnson got underway in London on Thursday, over claims its talcum powder caused cancer.
Johnson & Johnson agrees to pay £13bn for Switze... | 28-Apr-2011 | The Independent |
S&N DRIFTS AS BID HOPES SLIP | 19-Apr-2011 | Express & Star |
J&J asks judge to dismiss kickback case | 08-Oct-2010 | Wall Street Journal |
Genzyme Again Rejects Sanofi’s Bid | 08-Oct-2010 | New York Times |
Johnson & Johnson buying vaccine maker Crucell | 07-Oct-2010 | USA Today |
Currency | US Dollars |
Share Price | $ 192.12 |
Change Today | $ 0.95 |
% Change | 0.50 % |
52 Week High | $193.05 |
52 Week Low | $142.06 |
Volume | 10,611,760 |
Shares Issued | 2,406.92m |
Market Cap | $462,418m |
RiskGrade | 87 |
Strong Buy | 7 |
Buy | 5 |
Neutral | 13 |
Sell | 0 |
Strong Sell | 0 |
Total | 25 |
Time | Volume / Share Price |
15:59 | 100 @ $192.10 |
15:59 | 100 @ $192.07 |
15:59 | 100 @ $192.10 |
15:59 | 100 @ $192.07 |
15:59 | 100 @ $192.10 |
You are here: research